Estimates Revisions Silence Therapeutics plc OTC Markets
Stocks
SLNCF
GB00B9GTXM62
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
10:43:13 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 4.000 USD | -.--% |
|
-.--% | +100.00% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Silence Therapeutics plc(SLN)
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- SLN Stock
- SLNCF Stock
- Consensus Silence Therapeutics plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
